T cell lymphocyte (T cell)

T cells (T lymphocytes) are a major subset of white blood cells playing a central role in the adaptive immune system. They develop in the thymus and are characterized by the expression of the T-cell receptor (TCR), which enables recognition of antigens presented by other cells. Major T cell subsets include cytotoxic T cells (CD8+), which kill infected or cancerous cells; helper T cells (CD4+), which regulate immune responses by signaling other immune cells; regulatory T cells, which control immune tolerance; and memory T cells, which provide long-term protection against previously encountered pathogens. Therapeutic manipulation of patient’s T cells includes immunotherapy approaches targeting cancer, autoimmune disease, and transplantation; specific drugs either activate, suppress, or genetically modify these cells[5][3][9][7]. Note: For structured datasets, “Patient’s T-cells” is not a molecule or receptor and should be replaced by the specific protein, receptor, or molecular complex of interest (e.g., T-cell receptor, CD3, CD4, PD-1)[5][3][2].

Other names

T lymphocyteT-cellT cell

- Blockade of immune checkpoints (e.g., anti-PD-1/PD-L1, releases inhibition of T-cell cytotoxic function) - Activation of T-cell mediated cytotoxicity (CAR-T, engineered receptors stimulate T cell killing of cancer cells) - Suppression of T-cell activation (calcineurin inhibitors block IL-2 production and proliferation) - Depletion of T cells (cytotoxic antibodies promote T cell destruction)